Akeso, Inc. (AKESF)
Akeso, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
$12.50+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-36.7%
The outlook
Akeso, Inc. currently reads as leaning bearish based on mixed vs its moving averages, 16% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range16% of the way from its 52-week low to high
Market cap
$11.51B
52-wk high
$23.15
52-wk low
$10.50
50-day avg
$12.50
200-day avg
$14.47
Trailing P/E
—